Nondepleting anti-CD4 monoclonal antibody enhances the ability of oral alloantigen delivery to induce indefinite survival of cardiac allografts: oral tolerance to alloantigen.
BACKGROUND: We examined whether oral administration of alloantigen could induce the prolonged survival of cardiac allografts. METHODS: Hearts from CBK (H2k+Kb) transgenic or (C57BL/10xCBA)F1 (H2bxH2k) mice were transplanted into CBA (H2k) recipients pretreated orally with 1 x 10(7) donor splenocytes...
Główni autorzy: | Niimi, M, Witzke, O, Bushell, A, Hara, M, Morris, P, Wood, K |
---|---|
Format: | Journal article |
Język: | English |
Wydane: |
2000
|
Podobne zapisy
-
Oral administration of alloantigen plus nondepleting anti-CD4 monoclonal antibody induces indefinite prolongation of fully allogeneic cardiac allografts.
od: Niimi, M, i wsp.
Wydane: (2000) -
Oral delivery of alloantigen combined with non-depleting anti-CD4 monoclonal antibody induces indefinite survival of cardiac allografts and generates CD4(+) regulatory T cells.
od: Niimi, M, i wsp.
Wydane: (2000) -
Cytokines and peripheral tolerance to alloantigen
od: Dallman, M, i wsp.
Wydane: (1993) -
Cytokines and peripheral tolerance to alloantigen.
od: Dallman, M, i wsp.
Wydane: (1993) -
IL-10 is required for regulatory T cells to mediate tolerance to alloantigens in vivo.
od: Hara, M, i wsp.
Wydane: (2001)